Hong Kong Life Sciences and Technology Group Ltd ($8085) - buy or sell? Stock discussion, ideas, forum

Hong Kong Life Sciences and Technology Group Ltd

Hong Kong Life Sciences and Technologies Group Ltd is an investment holding company.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$8085	HKEx GEM	KYG4642K1040	Code: 8085

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 8085 stock

Share your investment idea or question on Hong Kong Life Sciences and Technology Group Ltd stock:

Latest twits on Hong Kong Life Sciences and Technology Group Ltd (8085)

No twits yet. Be the first to post!

Have a question about 8085? Ask and other investors will be eager to help you.

Have an idea about 8085? Share it with other investors.

Hong Kong Life Sciences and Technology Group Ltd news

24/06/2016 Hong Kong Life Sciences and Technology Group Ltd revenue decline accelerated to 61.5% in FY2016 vs. 52.9% a year earliner

24/06/2015 Hong Kong Life Sciences and Technology Group Ltd reports 112% CAPEX growth while 52.9% Revenue decline

Hong Kong Life Sciences and Technology Group Ltd stock price chart

Hong Kong Life Sciences and Technology Group Ltd financials

mln. HKD	FY2010	FY2011	FY2012

Revenue	74.505	79.733	71.727
EBITDA	6.192	4.028	-0.480
Net income	-39.769	-8.930	-28.448
CAPEX	7.051	9.475	5.001
Debt	3.412	4.749	18.504
Cash	72.657	99.961	108.9

Hong Kong Life Sciences and Technology Group Ltd news

About Hong Kong Life Sciences and Technology Group Ltd

Hong Kong Life Sciences and Technologies Group Ltd is an investment holding company. The Group is principally engaged in the sale of healthcare products in Hong Kong; the sale of electronic components in Hong Kong and The People's Republic of China (the "PRC"); the funeral and related businesses in the PRC; and the stem cell technology business.